<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105994">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02044562</url>
  </required_header>
  <id_info>
    <org_study_id>13-07-08</org_study_id>
    <nct_id>NCT02044562</nct_id>
  </id_info>
  <brief_title>Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients</brief_title>
  <official_title>Study of Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemo-radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether dietary nitrate supplementation could
      improve the plasma nitrate levels for nasopharyngeal carcinoma patients receiving concurrent
      chemo-radiation therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients diagnosed as nasopharyngeal carcinoma will be recruited. A 70 ml beetroot
      juice containing 0.45g nitrate or placebo will be provided to the patients for 7 days at the
      end of the radiotherapy . The plasma nitrate levels will be determined before radiotherapy,
      before intervention and after intervention.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>plasma nitrate level</measure>
    <time_frame>one day after nitrate supplementation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The plasma nitrate level will be determined one day after nitrate supplementation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>one day after nitrate supplementation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The quality of life will be assessed one day after nitrate supplementation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Nasopharyngeal Carcinoma</condition>
  <arm_group>
    <arm_group_label>nitrate supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 7-day nitrate supplementation at the end of the radiotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive 7-day placebo supplementation at the end of the radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>nitrate supplementation</intervention_name>
    <description>A 70 ml beetroot juice containing 0.45g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.</description>
    <arm_group_label>nitrate supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A 70 ml placebo containing 0 g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with newly diagnosed stages III-IVb (UICC 2002) nasopharyngeal carcinomas,
             will be recruited.

        Exclusion Criteria:

          -  Patients with local invasion or metastatic foci in salivary glands, detected by MRI
             and PET-CT prior to treatment, were excluded, as were patients suffering from
             diseases, such as Sjogren's syndrome, or with a history of surgery to major salivary
             glands, or prior head and neck radiotherapy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Songlin Wang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor and Vice President of Capital Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Capital Medical University School of Stomatology</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xingmin Qu</last_name>
      <phone>8610-57099421</phone>
      <email>xingminqu@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 22, 2014</lastchanged_date>
  <firstreceived_date>January 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Songlin Wang</investigator_full_name>
    <investigator_title>Professor and Vice President</investigator_title>
  </responsible_party>
  <keyword>dietary nitrate</keyword>
  <keyword>radiotherapy</keyword>
  <keyword>nasopharyngeal carcinoma</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
